Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

DHL to join forces with Evri in UK

(Sharecast News) - Germany's DHL Group is to take a "significant" minority stake in British parcel delivery firm Evri, it was announced on Wednesday. Under the terms of the deal, DHL's UK e-commerce arm will merge with Evri, which was acquired by US private equity firm Apollo in 2024 from Advent International for around £2.7bn.

Financial terms were not disclosed, although DHL confirmed that Evri - which rebranded from Hermes in 2022 - would remain majority-owned by Apollo.

The deal is set to create a major UK carrier capable of delivering more than 1bn parcels a year, as well as seeing Evri enter the business letter market. DHL said the merged entity would be able to deliver 1bn business letters annually.

Pablo Ciano, chief executive of DHL eCommerce, said: "Together, we'll be able to offer more efficient, far-reaching and innovative solutions to keep up with the fast-paced e-commerce market."

Martijn de Lange, Evri chief executive, said the deal would bring together "two highly complementary UK businesses".

He continued: "By combining Evri's scale, innovation and DHL eCommerce's premium van network, we are creating the pre-eminent parcel delivery group in the UK."

The combined business, which will be led by De Lange, will have 8,000 vehicles and around 30,000 couriers and drivers.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.